About: Conversion to Bosentan From Prostacyclin Infusion Therapy in Pulmonary Arterial Hypertension

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Conversion to Bosentan From Prostacyclin Infusion Therapy in Pulmonary Arterial Hypertension Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 2006 (uk) im November 2006 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en payares de 2006 (ast) scientific article published on 01 November 2006 (en)
publication date	wds:Q58485989-1F6D2DBA-8291-4E2A-A2A5-884A7CC92A69
publication date	2006-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58485989-F560B3CE-DB38-495B-986C-F6B877F8D509
language of work or name	English
author name string	wds:Q58485989-2CC9A663-D5D2-45A7-BC13-A462D6B3B95C wds:Q58485989-42A3DA03-87F8-43E7-A99B-8A69CB5A8E5E wds:Q58485989-4E62DCF1-A428-4C84-9227-77FA3011DCB8 wds:Q58485989-E2507E4F-191F-441B-81B0-18D45A0FEE2D wds:Q58485989-E70BDA7E-A568-4107-8E96-14B4096CB35F wds:Q58485989-EE4A32CA-B3FE-4AA1-8284-294F83E9DCB4
author name string	Ioana R Preston Nicholas S Hill Gerard J Criner James R Klinger Aaron B Waxman M Kathryn Steiner
rdfs:label	Conversion to Bosentan From Prostacyclin Infusion Therapy in Pulmonary Arterial Hypertension (en) Conversion to Bosentan From Prostacyclin Infusion Therapy in Pulmonary Arterial Hypertension (nl)
skos:prefLabel	Conversion to Bosentan From Prostacyclin Infusion Therapy in Pulmonary Arterial Hypertension (en) Conversion to Bosentan From Prostacyclin Infusion Therapy in Pulmonary Arterial Hypertension (nl)
name	Conversion to Bosentan From Prostacyclin Infusion Therapy in Pulmonary Arterial Hypertension (en) Conversion to Bosentan From Prostacyclin Infusion Therapy in Pulmonary Arterial Hypertension (nl)
author	wds:Q58485989-0F8C8FBF-3679-4A14-ABDA-AA34877E530D
author	Harrison W Farber
title	wds:Q58485989-59B69FEB-E551-4446-A9D5-24C3AAE09929
title	Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study (en)
page(s)	wds:Q58485989-CCCD1B1E-9042-48ED-BDEE-BC80BB687216
page(s)	1471-1480
instance of	wds:Q58485989-304255DC-BFC8-4764-978B-B179FC5041CF
instance of	scholarly article
main subject	wds:Q58485989-E40C3643-C70B-43CA-8AA0-08B3A9E9CE9D
main subject	arterial hypertension
PubMed ID	wds:Q58485989-01352344-1635-4321-BD03-394021ADE63B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17099026
PubMed ID	17099026
published in	wds:Q58485989-56DE409A-F0E6-4F9B-8649-BB504FE3DB51
published in	Chest
issue	wds:Q58485989-0DEF3296-6672-4934-A427-F0BF24B007A0
volume	wds:Q58485989-67CC3F96-BD81-430C-AFBA-BD73FC9E2B87
issue	5
volume	130
DOI	wds:Q58485989-EB66A1FD-38DA-4B1E-AEA5-346E26A07E4B
DOI	http://dx.doi.org/10.1378/CHEST.130.5.1471
DOI	10.1378/CHEST.130.5.1471
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58485989
is cites work of	A systematic review of transition studies of pulmonary arterial hypertension specific medications Transition from prostacyclin analogue infusion to oral therapy in patients with pulmonary arterial hypertension: a 5-year follow-up Transition from intravenous epoprostenol to oral or subcutaneous therapy in pulmonary arterial hypertension: a retrospective case series and systematic review Safety and efficacy of transition from inhaled treprostinil to parenteral treprostinil in selected patients with pulmonary arterial hypertension Review of bosentan in the management of pulmonary arterial hypertension Right ventricular failure complicating heart failure: pathophysiology, significance, and management strategies Safety and tolerability of bosentan in the management of pulmonary arterial hypertension Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH). Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension Bosentan for the treatment of adult pulmonary hypertension Pulmonary hypertension and breathlessness: is it a combination we can ignore? Right ventricular afterload predicts long-term transition from parenteral to oral treprostinil in pulmonary arterial hypertension Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension. Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH.
is cites work of	wds:Q33788548-12CA17D7-A41B-4840-A860-A0A1E5A92C5F wds:Q36596818-316EABEA-2977-4A7B-9400-25A8BAC3BE62 wds:Q33806206-49B78086-28A2-44F6-AFE3-38992D55C26C wds:Q37403190-902AB077-D306-4C14-B2F1-445905CF0ABC wds:Q41926707-48044EBA-C378-49BC-AA94-17425444B4B4 wds:Q92870460-98C228E9-7CB3-4EE0-9275-83FFB9608FB8 wds:Q38175197-CEDF040A-BE63-42E2-897F-BEEA69BCDFEB wds:Q58733985-6D2DD769-EC63-4F01-A454-DC3BA3154503 wds:Q36810780-981C28B3-3680-4A0A-8BD4-B72DDAB1F512 wds:Q37019838-72D37A86-C4D0-467B-94CE-D3831484A8EB wds:Q55193715-2C0921CF-BBC8-4C73-B0D0-38CC48FF6C83 wds:Q37822722-A2186269-D2EE-4CB4-B8E7-3A7D57F4C1C1 wds:Q35895629-6D3630D8-02AC-4501-AD0D-DC41F4EFDCD5 wds:Q36806960-378EF293-64F2-4077-B928-02005DC9F509 wds:Q33788506-95C62EB2-48CB-4425-BD08-A096AC9C2B43

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software